---
figid: PMC4231421__3141f7
figlink: /pmc/articles/PMC4231421/figure/F7/
number: Figure 7
caption: 'Schematic representation of LPA-dependent platelet-induced tumor cell metastasis.
  Tumor cell-induced platelet production of bioactive LPA (inhibitor: LPA receptor
  antagonist Ki16425) requires a first step of platelet aggregation that is prevented
  by selective inhibitors of αIIbβ3 integrin (RGDS, ReoPro), adenosine 5′-diphosphate
  activating pathway (Apyrase), and P2Y12 inhibitor (Clopidogrel). The second step
  requires the activation of phospholipases A1 and A2 (inhibitor: Palmostatin B) degrading
  membrane phospholipids among direct (phosphatidic acid) or indirect (phosphatidylcholine,
  phosphatidylserine, and phosphatidylethanolamine) precursors of LPA (LPC, lysophosphatidylserine,
  and lysophosphatidylethanolamine), that in turn are hydrolyzed by ATX/LysoPLD (ATX;
  lysoPLD inhibitors: BMP22 en PF-8380), released by activated platelets acting as
  free enzymes and/or bound to β3 integrins (αIIbβ3 and αVβ3). LPE, lysophosphatidylethanolamine;
  LPS, lysophosphatidyserine; PA, phosphatidic acid; PC, phosphatidylcholine; PE,
  phosphatidylethanolamine; PLA1, phospholipase A1; PLA2, phospholipase A2; PS, phosphatidylserine.'
pmcid: PMC4231421
papertitle: Interaction of platelet-derived autotaxin with tumor integrin αVβ3 controls
  metastasis of breast cancer cells to bone.
reftext: Raphael Leblanc, et al. Blood. 2014 Nov 13;124(20):3141-3150.
pmc_ranked_result_index: '194513'
pathway_score: 0.9296609
filename: 3141f7.jpg
figtitle: LPA-dependent platelet-induced tumor cell metastasis
year: '2014'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4231421__3141f7.html
  '@type': Dataset
  description: 'Schematic representation of LPA-dependent platelet-induced tumor cell
    metastasis. Tumor cell-induced platelet production of bioactive LPA (inhibitor:
    LPA receptor antagonist Ki16425) requires a first step of platelet aggregation
    that is prevented by selective inhibitors of αIIbβ3 integrin (RGDS, ReoPro), adenosine
    5′-diphosphate activating pathway (Apyrase), and P2Y12 inhibitor (Clopidogrel).
    The second step requires the activation of phospholipases A1 and A2 (inhibitor:
    Palmostatin B) degrading membrane phospholipids among direct (phosphatidic acid)
    or indirect (phosphatidylcholine, phosphatidylserine, and phosphatidylethanolamine)
    precursors of LPA (LPC, lysophosphatidylserine, and lysophosphatidylethanolamine),
    that in turn are hydrolyzed by ATX/LysoPLD (ATX; lysoPLD inhibitors: BMP22 en
    PF-8380), released by activated platelets acting as free enzymes and/or bound
    to β3 integrins (αIIbβ3 and αVβ3). LPE, lysophosphatidylethanolamine; LPS, lysophosphatidyserine;
    PA, phosphatidic acid; PC, phosphatidylcholine; PE, phosphatidylethanolamine;
    PLA1, phospholipase A1; PLA2, phospholipase A2; PS, phosphatidylserine.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PDGFB
  - PDGFC
  - IRF6
  - PCOLCE
  - PDGFA
  - VEGFA
  - P2RY12
  - PDGFD
  - PLA2G12A
  - PCSK7
  - VEGFB
  - LPA
  - PC
  - PLA2G1B
  - PLA2G2E
  - PLA2G2C
  - VEGFC
  - EGF
  - RALGDS
  - PLA2G2A
  - PLA2G7
  - PLA2G3
  - PLA2G6
  - PLA2G10
  - PLA2G12B
  - PLA2G4A
  - PLA2G4C
  - PLA2G2D
  - PGF
  - WDTC1
  - VEGFD
  - PLA2G4D
  - PLA2G5
  - PLA2G2F
  - POU2F3
genes:
- word: PDGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFB
  entrez: '5155'
- word: PDGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFC
  entrez: '56034'
- word: LPS
  symbol: LPS
  source: hgnc_prev_symbol
  hgnc_symbol: IRF6
  entrez: '3664'
- word: PC,PE,PS
  symbol: PCPE
  source: hgnc_alias_symbol
  hgnc_symbol: PCOLCE
  entrez: '5118'
- word: PDGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFA
  entrez: '5154'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: P2Y12
  symbol: P2Y12
  source: hgnc_alias_symbol
  hgnc_symbol: P2RY12
  entrez: '64805'
- word: PDGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFD
  entrez: '80310'
- word: PLA2?
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G12A
  entrez: '81579'
- word: LPC,
  symbol: LPC
  source: hgnc_alias_symbol
  hgnc_symbol: PCSK7
  entrez: '9159'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: LPA
  symbol: LPA
  source: hgnc_symbol
  hgnc_symbol: LPA
  entrez: '4018'
- word: PC,
  symbol: PC
  source: hgnc_symbol
  hgnc_symbol: PC
  entrez: '5091'
- word: PLA2?
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G1B
  entrez: '5319'
- word: PLA2?
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G2E
  entrez: '30814'
- word: PLA2?
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G2C
  entrez: '391013'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: EGF..
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: RGDS
  symbol: RGDS
  source: hgnc_alias_symbol
  hgnc_symbol: RALGDS
  entrez: '5900'
- word: PLA2?
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G2A
  entrez: '5320'
- word: PLA2?
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G7
  entrez: '7941'
- word: PLA2?
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G3
  entrez: '50487'
- word: PLA2?
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G6
  entrez: '8398'
- word: PLA2?
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G10
  entrez: '8399'
- word: PLA2?
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G12B
  entrez: '84647'
- word: PLA2?
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G4A
  entrez: '5321'
- word: PLA2?
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G4C
  entrez: '8605'
- word: PLA2?
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G2D
  entrez: '26279'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: ADP
  symbol: ADP
  source: hgnc_alias_symbol
  hgnc_symbol: WDTC1
  entrez: '23038'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: PLA2?
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G4D
  entrez: '283748'
- word: PLA2?
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G5
  entrez: '5322'
- word: PLA2?
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G2F
  entrez: '64600'
- word: PLA1
  symbol: PLA-1
  source: hgnc_alias_symbol
  hgnc_symbol: POU2F3
  entrez: '25833'
chemicals: []
diseases: []
---
